세계의 욕창 디바이스 시장 : 제품 유형, 최종사용자, 지역별 - 산업 분석, 규모, 점유율, 성장, 동향, 예측(2024-2032년)

Persistence Market Research offers a comprehensive analysis of the global pressure ulcer devices market, providing key insights into market dynamics, growth drivers, challenges, and emerging trends. This report offers exclusive data and statistics forecasting the trajectory of the pressure ulcer devices market from 2024 to 2032.

Revenue from the global pressure ulcer devices market reached US$ 5.5 Bn in 2024. With the market projected to expand at a steady 5.5% CAGR, industry valuation is set to top US$ 8.4 Bn by the end of 2032.

Key Insights:

• Pressure Ulcer Devices Market Size (2024): US$ 5.5 Bn
• Projected Market Value (2032):US$ 8.4 Bn
• Global Market Growth Rate (2024-2032):5.5%

Pressure Ulcer Devices Market - Report Scope:

Pressure ulcer devices are essential in preventing and managing pressure ulcers, also known as bedsores or pressure sores, which commonly occur in individuals with limited mobility. These devices include mattresses, cushions, overlays, and specialty beds designed to redistribute pressure, reduce friction, and manage moisture, thus preventing the development of pressure ulcers. The market encompasses a wide range of products catering to various healthcare settings, including hospitals, nursing homes, and home care.

The global pressure ulcer devices market is primarily driven by the increasing prevalence of chronic conditions such as immobility, diabetes, and obesity, which elevate the risk of pressure ulcer development. Additionally, the growing aging population worldwide contributes to the rising demand for pressure ulcer prevention and management solutions. Technological advancements in pressure redistribution surfaces, such as alternating pressure mattresses and low-air-loss mattresses, further fuel market growth by enhancing patient comfort and efficacy in pressure ulcer prevention.

Market Growth Drivers:

The aging population demographic is a significant driver of market growth, as elderly individuals are more susceptible to pressure ulcer development due to factors such as reduced mobility, thinning skin, and comorbidities. With a globally increasing proportion of elderly individuals, particularly in developed regions, the demand for pressure ulcer prevention and management devices is expected to surge.

Moreover, advancements in healthcare infrastructure and increased awareness regarding pressure ulcer prevention among healthcare providers contribute to market expansion. Healthcare facilities are increasingly investing in advanced pressure redistribution surfaces to improve patient outcomes and reduce the economic burden associated with pressure ulcer treatment.

Market Restraints:

One of the key challenges faced by the pressure ulcer devices market is the high cost associated with advanced pressure redistribution surfaces. While these devices offer superior pressure ulcer prevention and management capabilities, their high upfront costs can deter adoption, particularly in healthcare settings with budget constraints.

Additionally, inadequate reimbursement policies for pressure ulcer prevention devices in certain regions hinder market growth. Limited insurance coverage for pressure ulcer prevention and management products reduces their affordability for patients, thereby limiting market penetration.

Market Opportunities:

The growing focus on home-based healthcare and the rise of telemedicine present significant opportunities for the pressure ulcer devices market. As healthcare delivery shifts towards decentralized settings, there is a heightened demand for portable and user-friendly pressure redistribution surfaces suitable for home use. Manufacturers can capitalize on this trend by developing innovative products tailored to the needs of home caregivers and patients.

Furthermore, the integration of smart technologies such as sensors and connectivity features into pressure ulcer devices opens up avenues for remote monitoring and data-driven care. Smart pressure redistribution surfaces equipped with monitoring capabilities enable healthcare providers to track patient compliance, assess risk factors, and intervene proactively, thereby improving clinical outcomes and reducing hospital readmissions.

Key Questions Answered in the Report:

• Which regions are poised to exhibit the highest demand for pressure ulcer devices?
• What are the prevailing trends in pressure ulcer prevention and management strategies?
• How do regulatory frameworks impact the adoption of pressure ulcer devices globally?
• Who are the key players driving innovation and market expansion in the pressure ulcer devices segment?
• What are the emerging technological trends shaping the future of the pressure ulcer devices market?

Competitive Intelligence and Business Strategy:

Leading players in the pressure ulcer devices market focus on product innovation, strategic collaborations, and geographical expansion to maintain their competitive edge. Companies invest in research and development to introduce advanced features such as pressure sensing technology, temperature regulation, and antimicrobial properties in their products, enhancing their clinical efficacy and market appeal.

Key Companies Profiled:

• Stryker Corp.
• Smith & Nephew Plc.
• Hill-Rom Services Inc.
• Paramount Bed Holdings Co., Ltd.
• ArjoHuntleigh
• Talley Group Limited
• Drive DeVilbiss Healthcare Ltd (Sidhil Limited)
• Apex Medical Corp.
• Medtronic
• PROMA REHA, s. r. o.
• Linet spol. S R.O.
• DARCO International
• DeRoyal Industries
• BSN Medical (Essity)
• Molnlycke Health Care
• TrueKAST (Wound Kair Concepts)
• Thuasne SAS
• DJO Global
• ORTHOSERVICE AG
• Breg, Inc.
• Advanced Orthopaedics
• ALGEOS
• Hollister Incorporated
• ConvaTec Group plc
• Coloplast A/S
• Medline Industries Inc.
• Invacare Corporation

Pressure Ulcer Devices Market Research Segmentation:

Pressure Ulcer Devices Market by Product:

• Mattress Overlays
• Pressure Relief Mattresses

oFoam-based Mattress

oGel-based Mattress

oFiber-filled Mattress

oWater/Fluid-filled Mattress

oAir-filled Mattress

• Speciality Beds

oKinetic Beds

oAir-Fluidized Beds

• Pressure Relief Cushions
• Alternating Pressure Wheelchair's Cushions
• Off-Loading Devices

oTotal Contact Casting Systems

§Casting System with Boots

§Casting System without Boot

oOff-loading Shoes

§Post-Operative Offloading Shoes

§Wedge-based Shoes

§All Purpose Shoes

§Off-loading insoles

• Pressure Relief Accessories
• Advanced Wound Dressings

oAlginate Dressings

oCollagens Dressings

oFilms Dressing

oFoam Dressings

§Anti-microbial Foam Dressing

§Non-Anti-Microbial Foam Dressing

oHydrocolloids Dressing

oHydrofibers Dressings

oHydrogels Dressings

oSuperabsorbent Dressing

oWound Contact Layers

Pressure Ulcer Devices Market by Stage:

• Stage I Pressure Ulcer Devices
• Stage II Pressure Ulcer Devices
• Stage III Pressure Ulcer Devices
• Stage IV Pressure Ulcer Devices

Pressure Ulcer Devices Market by End User:

• Hospitals
• Long-term Care Centres
• Skilled Nursing Facilities
• Home Care Settings

Pressure Ulcer Devices Market by Region:

• North America
• Europe
• East Asia
• South Asia & Oceania
• Latin America
• Middle East & Africa

Table of Contents

1. Executive Summary

• 1.1. Global Market Outlook
• 1.2. Demand Side Trends
• 1.3. Supply Side Trends
• 1.4. Analysis and Recommendations

2. Market Overview

• 2.1. Market Coverage / Taxonomy
• 2.2. Market Definition / Scope / Limitations
• 2.3. Inclusions and Exclusions

3. Key Market Trends

• 3.1. Key Trends Impacting the Market
• 3.2. Product Innovation / Development Trends

4. Value Added Insights

• 4.1. Pressure Relief Devices Adoption Analysis, By Region
• 4.2. Disease Epidemiology, By Country
• 4.3. Key Marketing & Promotional Strategies, By Manufacturers
• 4.4. Value Chain Analysis
• 4.5. Regulatory Scenario
• 4.6. Reimbursement Landscape
• 4.7. PESTLE Analysis
• 4.8. Porter's Analysis

5. Specific Insights

• 5.1. Current PU Prevention Modalities, By End User Settings (ED/Acute Care/ICU's/HDU's/Operating Theatre/Nursing Facilities/Long Term Care/Home Care Settings)
• 5.2. Role of dressings in pressure ulcer Prevention
• 5.3. Evidences & Standard of Care of PU preventions, By Setting in Asia Pacific countries
• 5.4. Current challenges in PU prevention
• 5.5. Key Trends in PU Prevention, by region

6. Market Background

• 6.1. Macro-Economic Factors
  • 6.1.1. Global GDP Growth Outlook
  • 6.1.2. Global Healthcare Outlook
• 6.2. Forecast Factors - Relevance & Impact
  • 6.2.1. Hospital Bed Capacity Per Facility, by Country
  • 6.2.2. Lifespan of Hospital Equipment, Replacement Cycle and New Sales
  • 6.2.3. Adoption of Devices
  • 6.2.4. Prevalence of Pressure Ulcer
  • 6.2.5. Average Cost of Treatment
• 6.3. Market Dynamics
  • 6.3.1. Drivers
  • 6.3.2. Restraints
  • 6.3.3. Opportunity Analysis

7. COVID19 Crisis Analysis

• 7.1. Current COVID19 Statistics and Probable Future Impact
• 7.2. Current GDP Projection and Probable Impact
• 7.3. COVID19 and Impact Analysis
  • 7.3.1. By Region
  • 7.3.2. By Product
  • 7.3.3. By Stages
  • 7.3.4. By End User

8. Global Pressure Ulcer Devices Market - Pricing Analysis

• 8.1. Regional Pricing Analysis By Product
• 8.2. Global Average Pricing Analysis Benchmark

9. Global Pressure Ulcer Devices Market Demand (Volume in thousand units) Analysis 2019-2023 and Forecast, 2024-2032

• 9.1. Historical Market Volume (Thousand Units) Analysis, 2019-2023
• 9.2. Current and Future Market Volume (Thousand Units) Projections, 2024-2032
  • 9.2.1. Y-o-Y Growth Trend Analysis
  • 9.2.2. Absolute $ Opportunity Analysis

10. Global Pressure Ulcer Devices Market Demand (in Value or Size in US$ Mn) Analysis 2019-2023 and Forecast, 2024-2032

• 10.1. Historical Market Value (US$ Mn) Analysis, 2019-2023
• 10.2. Current and Future Market Value (US$ Mn) Projections, 2024-2032
  • 10.2.1. Y-o-Y Growth Trend Analysis

11. Global Pressure Ulcer Devices Market Analysis 2019-2023 and Forecast 2024-2032, by Product

• 11.1. Introduction / Key Findings
• 11.2. Historical Market Size (US$ Mn) Analysis By Product, 2019-2023
• 11.3. Current and Future Market Size (US$ Mn) and Forecast By Product, 2024-2032
  • 11.3.1. Mattress Overlays
  • 11.3.2. Pressure Relief Mattresses
    • 11.3.2.1. Foam-based Mattress
    • 11.3.2.2. Gel-based Mattress
    • 11.3.2.3. Fiber-filled Mattress
    • 11.3.2.4. Water/Fluid-filled Mattress
    • 11.3.2.5. Air-filled Mattress
  • 11.3.3. Speciality Beds
    • 11.3.3.1. Kinetic Beds
    • 11.3.3.2. Air-Fluidized Beds
  • 11.3.4. Pressure Relief Cushions
  • 11.3.5. Alternating Pressure Wheelchair's Cushions
  • 11.3.6. Off-Loading Devices
    • 11.3.6.1. Total Contact Casting Systems
      • 11.3.6.1.1. Casting System with Boots
      • 11.3.6.1.2. Casting System without Boot
    • 11.3.6.2. Off-loading Shoes
      • 11.3.6.2.1. Post-Operative Offloading Shoes
      • 11.3.6.2.2. Wedge-based Shoes
      • 11.3.6.2.3. All Purpose Shoes
      • 11.3.6.2.4. Off-loading insoles
  • 11.3.7. Pressure Relief Accessories
  • 11.3.8. Advanced Wound Dressings
    • 11.3.8.1. Alginate Dressings
    • 11.3.8.2. Collagens Dressings
    • 11.3.8.3. Films Dressing
    • 11.3.8.4. Foam Dressings
      • 11.3.8.4.1. Anti-microbial Foam Dressing
      • 11.3.8.4.2. Non-Anti-Microbial Foam Dressing
    • 11.3.8.5. Hydrocolloids Dressing
    • 11.3.8.6. Hydrofibers Dressings
    • 11.3.8.7. Hydrogels Dressings
    • 11.3.8.8. Superabsorbent Dressing
    • 11.3.8.9. Wound Contact Layers
• 11.4. Market Attractiveness Analysis By Product

12. Global Pressure Ulcer Devices Market Analysis 2019-2023 and Forecast 2024-2032, by Stages

• 12.1. Introduction / Key Findings
• 12.2. Historical Market Size (US$ Mn) Analysis by Stages, 2019-2023
• 12.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Stages, 2024-2032
  • 12.3.1. Stage I
  • 12.3.2. Stage II
  • 12.3.3. Stage III
  • 12.3.4. Stage IV
• 12.4. Market Attractiveness Analysis By Stages

13. Global Pressure Ulcer Devices Market Analysis 2019-2023 and Forecast 2024-2032, by End User

• 13.1. Introduction / Key Findings
• 13.2. Historical Market Size (US$ Mn) Analysis by End User, 2019-2023
• 13.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by End User, 2024-2032
  • 13.3.1. Hospitals
  • 13.3.2. Long-term Care Centres
  • 13.3.3. Skilled Nursing Facilities
  • 13.3.4. Home Care Settings
• 13.4. Market Attractiveness Analysis by End User

14. Global Pressure Ulcer Devices Market Analysis 2019-2023 and Forecast 2024-2032, by Region

• 14.1. Introduction
• 14.2. Historical Market Size (US$ Mn) Analysis by Region, 2019-2023
• 14.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Region, 2024-2032
  • 14.3.1. North America
  • 14.3.2. Latin America
  • 14.3.3. Europe
  • 14.3.4. South Asia
  • 14.3.5. East Asia
  • 14.3.6. Oceania
  • 14.3.7. Middle East and Africa (MEA
• 14.4. Market Attractiveness Analysis by Region

15. North America Pressure Ulcer Devices Market Analysis 2019-2023 and Forecast 2024-2032

• 15.1. Introduction
• 15.2. Historical Market Size (US$ Mn) Trend Analysis by Market Taxonomy, 2019-2023
• 15.3. Current and Future Market Size (US$ Mn) Forecast by Market Taxonomy, 2024-2032
  • 15.3.1. By Country
    • 15.3.1.1. U.S.
    • 15.3.1.2. Canada
  • 15.3.2. By Product
  • 15.3.3. By Stages
  • 15.3.4. By End User
• 15.4. Market Attractiveness Analysis
  • 15.4.1. By Country
  • 15.4.2. By Product
  • 15.4.3. By Stages
  • 15.4.4. By End User
• 15.5. Key Market Participants - Intensity Mapping
• 15.6. Drivers and Restraints - Impact Analysis

16. Latin America Pressure Ulcer Devices Market 2019-2023 and Forecast 2024-2032

• 16.1. Introduction
• 16.2. Historical Market Size (US$ Mn) Trend Analysis by Market Taxonomy, 2019-2023
• 16.3. Current and Future Market Size (US$ Mn) Forecast by Market Taxonomy, 2024-2032
  • 16.3.1. By Country
    • 16.3.1.1. Brazil
    • 16.3.1.2. Mexico
    • 16.3.1.3. Rest of Latin America
  • 16.3.2. By Product
  • 16.3.3. By Stages
  • 16.3.4. By End User
• 16.4. Market Attractiveness Analysis
  • 16.4.1. By Country
  • 16.4.2. By Product
  • 16.4.3. By Stages
  • 16.4.4. By End User
• 16.5. Key Market Participants - Intensity Mapping
• 16.6. Drivers and Restraints - Impact Analysis

17. Europe Pressure Ulcer Devices Market 2019-2023 and Forecast 2024-2032

• 17.1. Introduction
• 17.2. Historical Market Size (US$ Mn) Trend Analysis by Market Taxonomy, 2019-2023
• 17.3. Current and Future Market Size (US$ Mn) Forecast by Market Taxonomy, 2024-2032
  • 17.3.1. By Country
    • 17.3.1.1. Germany
    • 17.3.1.2. Italy
    • 17.3.1.3. France
    • 17.3.1.4. U.K.
    • 17.3.1.5. Spain
    • 17.3.1.6. BENELUX
    • 17.3.1.7. Russia
    • 17.3.1.8. Rest of Europe
  • 17.3.2. By Product
  • 17.3.3. By Stages
  • 17.3.4. By End User
• 17.4. Market Attractiveness Analysis
  • 17.4.1. By Country
  • 17.4.2. By Product
  • 17.4.3. By Stages
  • 17.4.4. By End User
• 17.5. Key Market Participants - Intensity Mapping
• 17.6. Drivers and Restraints - Impact Analysis

18. South Asia Pressure Ulcer Devices Market 2019-2023 and Forecast 2024-2032

• 18.1. Introduction
• 18.2. Historical Market Size (US$ Mn) Trend Analysis by Market Taxonomy, 2019-2023
• 18.3. Current and Future Market Size (US$ Mn) Forecast by Market Taxonomy, 2024-2032
  • 18.3.1. By Country
    • 18.3.1.1. India
    • 18.3.1.2. Thailand
    • 18.3.1.3. Indonesia
    • 18.3.1.4. Malaysia
    • 18.3.1.5. Rest of South Asia
  • 18.3.2. By Product
  • 18.3.3. By Stages
  • 18.3.4. By End User
• 18.4. Market Attractiveness Analysis
  • 18.4.1. By Country
  • 18.4.2. By Product
  • 18.4.3. By Stages
  • 18.4.4. By End User
• 18.5. Key Market Participants - Intensity Mapping
• 18.6. Drivers and Restraints - Impact Analysis

19. East Asia Pressure Ulcer Devices Market 2019-2023 and Forecast 2024-2032

• 19.1. Introduction
• 19.2. Historical Market Size (US$ Mn) Trend Analysis by Market Taxonomy, 2019-2023
• 19.3. Current and Future Market Size (US$ Mn) Forecast by Market Taxonomy, 2024-2032
  • 19.3.1. By Country
    • 19.3.1.1. China
    • 19.3.1.2. Japan
    • 19.3.1.3. South Korea
  • 19.3.2. By Product
  • 19.3.3. By Stages
  • 19.3.4. By End User
• 19.4. Market Attractiveness Analysis
  • 19.4.1. By Country
  • 19.4.2. By Product
  • 19.4.3. By Stages
  • 19.4.4. By End User
• 19.5. Key Market Participants - Intensity Mapping
• 19.6. Drivers and Restraints - Impact Analysis

20. Oceania Pressure Ulcer Devices Market 2019-2023 and Forecast 2024-2032

• 20.1. Introduction
• 20.2. Historical Market Size (US$ Mn) Trend Analysis by Market Taxonomy, 2019-2023
• 20.3. Current and Future Market Size (US$ Mn) Forecast by Market Taxonomy, 2024-2032
  • 20.3.1. By Country
    • 20.3.1.1. Australia
    • 20.3.1.2. New Zealand
  • 20.3.2. By Product
  • 20.3.3. By Stages
  • 20.3.4. By End User
• 20.4. Market Attractiveness Analysis
  • 20.4.1. By Country
  • 20.4.2. By Product
  • 20.4.3. By Stages
  • 20.4.4. By End User
• 20.5. Key Market Participants - Intensity Mapping
• 20.6. Drivers and Restraints - Impact Analysis

21. Middle East and Africa Pressure Ulcer Devices Market 2019-2023 and Forecast 2024-2032

• 21.1. Introduction
• 21.2. Historical Market Size (US$ Mn) Trend Analysis by Market Taxonomy, 2019-2023
• 21.3. Current and Future Market Size (US$ Mn) Forecast by Market Taxonomy, 2024-2032
  • 21.3.1. By Country
    • 21.3.1.1. GCC Countries
    • 21.3.1.2. Northern Africa
    • 21.3.1.3. South Africa
    • 21.3.1.4. Turkey
    • 21.3.1.5. Rest of Middle East and Africa
  • 21.3.2. By Product
  • 21.3.3. By Stages
  • 21.3.4. By End User
• 21.4. Market Attractiveness Analysis
  • 21.4.1. By Country
  • 21.4.2. By Product
  • 21.4.3. By Stages
  • 21.4.4. By End User
• 21.5. Key Market Participants - Intensity Mapping
• 21.6. Drivers and Restraints - Impact Analysis

22. Country Level Pressure Ulcer Devices Market Analysis 2022 & 2032

• 22.1. Introduction
  • 22.1.1. Market Value Proportion Analysis, By Key Countries
  • 22.1.2. Global Vs. Country Growth Comparison
• 22.2. U.S. Pressure Ulcer Devices Market Analysis
  • 22.2.1. By Product
  • 22.2.2. By Stages
  • 22.2.3. By End User
• 22.3. Canada Pressure Ulcer Devices Market Analysis
  • 22.3.1. By Product
  • 22.3.2. By Stages
  • 22.3.3. By End User
• 22.4. Mexico Pressure Ulcer Devices Market Analysis
  • 22.4.1. By Product
  • 22.4.2. By Stages
  • 22.4.3. By End User
• 22.5. Brazil Pressure Ulcer Devices Market Analysis
  • 22.5.1. By Product
  • 22.5.2. By Stages
  • 22.5.3. By End User
• 22.6. Germany Pressure Ulcer Devices Market Analysis
  • 22.6.1. By Product
  • 22.6.2. By Stages
  • 22.6.3. By End User
• 22.7. Italy Pressure Ulcer Devices Market Analysis
  • 22.7.1. By Product
  • 22.7.2. By Stages
  • 22.7.3. By End User
• 22.8. France Pressure Ulcer Devices Market Analysis
  • 22.8.1. By Product
  • 22.8.2. By Stages
  • 22.8.3. By End User
• 22.9. U.K. Pressure Ulcer Devices Market Analysis
  • 22.9.1. By Product
  • 22.9.2. By Stages
  • 22.9.3. By End User
• 22.10. Spain Pressure Ulcer Devices Market Analysis
  • 22.10.1. By Product
  • 22.10.2. By Stages
  • 22.10.3. By End User
• 22.11. BENELUX Pressure Ulcer Devices Market Analysis
  • 22.11.1. By Product
  • 22.11.2. By Stages
  • 22.11.3. By End User
• 22.12. Russia Pressure Ulcer Devices Market Analysis
  • 22.12.1. By Product
  • 22.12.2. By Stages
  • 22.12.3. By End User
• 22.13. China Pressure Ulcer Devices Market Analysis
  • 22.13.1. By Product
  • 22.13.2. By Stages
  • 22.13.3. By End User
• 22.14. Japan Pressure Ulcer Devices Market Analysis
  • 22.14.1. By Product
  • 22.14.2. By Stages
  • 22.14.3. By End User
• 22.15. South Korea Pressure Ulcer Devices Market Analysis
  • 22.15.1. By Product
  • 22.15.2. By Stages
  • 22.15.3. By End User
• 22.16. India Pressure Ulcer Devices Market Analysis
  • 22.16.1. By Product
  • 22.16.2. By Stages
  • 22.16.3. By End User
• 22.17. Thailand Pressure Ulcer Devices Market Analysis
  • 22.17.1. By Product
  • 22.17.2. By Stages
  • 22.17.3. By End User
• 22.18. Indonesia Pressure Ulcer Devices Market Analysis
  • 22.18.1. By Product
  • 22.18.2. By Stages
  • 22.18.3. By End User
• 22.19. Malaysia Pressure Ulcer Devices Market Analysis
  • 22.19.1. By Product
  • 22.19.2. By Stages
  • 22.19.3. By End User
• 22.20. Australia Pressure Ulcer Devices Market Analysis
  • 22.20.1. By Product
  • 22.20.2. By Stages
  • 22.20.3. By End User
• 22.21. New Zealand Pressure Ulcer Devices Market Analysis
  • 22.21.1. By Product
  • 22.21.2. By Stages
  • 22.21.3. By End User
• 22.22. GCC Countries Pressure Ulcer Devices Market Analysis
  • 22.22.1. By Product
  • 22.22.2. By Stages
  • 22.22.3. By End User
• 22.23. Turkey Pressure Ulcer Devices Market Analysis
  • 22.23.1. By Product
  • 22.23.2. By Stages
  • 22.23.3. By End User
• 22.24. Northern Africa Pressure Ulcer Devices Market Analysis
  • 22.24.1. By Product
  • 22.24.2. By Stages
  • 22.24.3. By End User
• 22.25. South Africa Pressure Ulcer Devices Market Analysis
  • 22.25.1. By Product
  • 22.25.2. By Stages
  • 22.25.3. By End User

23. Market Structure Analysis

• 23.1. Market Analysis by Tier of Companies
• 23.2. Market Share Analysis of Top Players
• 23.3. Market Presence Analysis
  • 23.3.1. By Regional Footprint of Players
  • 23.3.2. Product Footprint by Players
  • 23.3.3. Channel Footprint by Players

24. Competition Analysis

• 24.1. Competition Dashboard
• 24.2. Competition Benchmarking
• 24.3. Competition Deep Dive
  • 24.3.1. Stryker Corp.
    • 24.3.1.1. Overview
    • 24.3.1.2. Product Portfolio
    • 24.3.1.3. Key Financials
    • 24.3.1.4. Sales Footprint
    • 24.3.1.5. Analyst commentary
    • 24.3.1.6. Strategy Overview
      • 24.3.1.6.1. Marketing Strategy
      • 24.3.1.6.2. Product Strategy
      • 24.3.1.6.3. Channel Strategy
  • 24.3.2. Smith & Nephew Plc.
    • 24.3.2.1. Overview
    • 24.3.2.2. Product Portfolio
    • 24.3.2.3. Key Financials
    • 24.3.2.4. Sales Footprint
    • 24.3.2.5. Analyst commentary
    • 24.3.2.6. Strategy Overview
      • 24.3.2.6.1. Marketing Strategy
      • 24.3.2.6.2. Product Strategy
      • 24.3.2.6.3. Channel Strategy
  • 24.3.3. Hill-Rom Services Inc.
    • 24.3.3.1. Overview
    • 24.3.3.2. Product Portfolio
    • 24.3.3.3. Key Financials
    • 24.3.3.4. Sales Footprint
    • 24.3.3.5. Analyst commentary
    • 24.3.3.6. Strategy Overview
      • 24.3.3.6.1. Marketing Strategy
      • 24.3.3.6.2. Product Strategy
      • 24.3.3.6.3. Channel Strategy
  • 24.3.4. Paramount Bed Holdings Co., Ltd.
    • 24.3.4.1. Overview
    • 24.3.4.2. Product Portfolio
    • 24.3.4.3. Key Financials
    • 24.3.4.4. Sales Footprint
    • 24.3.4.5. Analyst commentary
    • 24.3.4.6. Strategy Overview
      • 24.3.4.6.1. Marketing Strategy
      • 24.3.4.6.2. Product Strategy
      • 24.3.4.6.3. Channel Strategy
  • 24.3.5. ArjoHuntleigh
    • 24.3.5.1. Overview
    • 24.3.5.2. Product Portfolio
    • 24.3.5.3. Key Financials
    • 24.3.5.4. Sales Footprint
    • 24.3.5.5. Analyst commentary
    • 24.3.5.6. Strategy Overview
      • 24.3.5.6.1. Marketing Strategy
      • 24.3.5.6.2. Product Strategy
      • 24.3.5.6.3. Channel Strategy
  • 24.3.6. Talley Group Limited
    • 24.3.6.1. Overview
    • 24.3.6.2. Product Portfolio
    • 24.3.6.3. Key Financials
    • 24.3.6.4. Sales Footprint
    • 24.3.6.5. Analyst commentary
    • 24.3.6.6. Strategy Overview
      • 24.3.6.6.1. Marketing Strategy
      • 24.3.6.6.2. Product Strategy
      • 24.3.6.6.3. Channel Strategy
  • 24.3.7. Drive DeVilbiss Healthcare Ltd (Sidhil Limited)
    • 24.3.7.1. Overview
    • 24.3.7.2. Product Portfolio
    • 24.3.7.3. Key Financials
    • 24.3.7.4. Sales Footprint
    • 24.3.7.5. Analyst commentary
    • 24.3.7.6. Strategy Overview
      • 24.3.7.6.1. Marketing Strategy
      • 24.3.7.6.2. Product Strategy
      • 24.3.7.6.3. Channel Strategy
  • 24.3.8. Apex Medical Corp.
    • 24.3.8.1. Overview
    • 24.3.8.2. Product Portfolio
    • 24.3.8.3. Key Financials
    • 24.3.8.4. Sales Footprint
    • 24.3.8.5. Analyst commentary
    • 24.3.8.6. Strategy Overview
      • 24.3.8.6.1. Marketing Strategy
      • 24.3.8.6.2. Product Strategy
      • 24.3.8.6.3. Channel Strategy
  • 24.3.9. Medtronic
    • 24.3.9.1. Overview
    • 24.3.9.2. Product Portfolio
    • 24.3.9.3. Key Financials
    • 24.3.9.4. Sales Footprint
    • 24.3.9.5. Analyst commentary
    • 24.3.9.6. Strategy Overview
      • 24.3.9.6.1. Marketing Strategy
      • 24.3.9.6.2. Product Strategy
      • 24.3.9.6.3. Channel Strategy
  • 24.3.10. PROMA REHA, s. r. o.
    • 24.3.10.1. Overview
    • 24.3.10.2. Product Portfolio
    • 24.3.10.3. Key Financials
    • 24.3.10.4. Sales Footprint
    • 24.3.10.5. Analyst commentary
    • 24.3.10.6. Strategy Overview
      • 24.3.10.6.1. Marketing Strategy
      • 24.3.10.6.2. Product Strategy
      • 24.3.10.6.3. Channel Strategy
  • 24.3.11. Linet spol. S R.O.
    • 24.3.11.1. Overview
    • 24.3.11.2. Product Portfolio
    • 24.3.11.3. Key Financials
    • 24.3.11.4. Sales Footprint
    • 24.3.11.5. Analyst commentary
    • 24.3.11.6. Strategy Overview
      • 24.3.11.6.1. Marketing Strategy
      • 24.3.11.6.2. Product Strategy
      • 24.3.11.6.3. Channel Strategy
  • 24.3.12. DARCO International
    • 24.3.12.1. Overview
    • 24.3.12.2. Product Portfolio
    • 24.3.12.3. Key Financials
    • 24.3.12.4. Sales Footprint
    • 24.3.12.5. Analyst commentary
    • 24.3.12.6. Strategy Overview
      • 24.3.12.6.1. Marketing Strategy
      • 24.3.12.6.2. Product Strategy
      • 24.3.12.6.3. Channel Strategy
  • 24.3.13. DeRoyal Industries
    • 24.3.13.1. Overview
    • 24.3.13.2. Product Portfolio
    • 24.3.13.3. Key Financials
    • 24.3.13.4. Sales Footprint
    • 24.3.13.5. Analyst commentary
    • 24.3.13.6. Strategy Overview
      • 24.3.13.6.1. Marketing Strategy
      • 24.3.13.6.2. Product Strategy
      • 24.3.13.6.3. Channel Strategy
  • 24.3.14. BSN Medical (Essity)
    • 24.3.14.1. Overview
    • 24.3.14.2. Product Portfolio
    • 24.3.14.3. Key Financials
    • 24.3.14.4. Sales Footprint
    • 24.3.14.5. Analyst commentary
    • 24.3.14.6. Strategy Overview
      • 24.3.14.6.1. Marketing Strategy
      • 24.3.14.6.2. Product Strategy
      • 24.3.14.6.3. Channel Strategy
  • 24.3.15. Molnlycke Health Care
    • 24.3.15.1. Overview
    • 24.3.15.2. Product Portfolio
    • 24.3.15.3. Key Financials
    • 24.3.15.4. Sales Footprint
    • 24.3.15.5. Analyst commentary
    • 24.3.15.6. Strategy Overview
      • 24.3.15.6.1. Marketing Strategy
      • 24.3.15.6.2. Product Strategy
      • 24.3.15.6.3. Channel Strategy
  • 24.3.16. TrueKAST (Wound Kair Concepts)
    • 24.3.16.1. Overview
    • 24.3.16.2. Product Portfolio
    • 24.3.16.3. Key Financials
    • 24.3.16.4. Sales Footprint
    • 24.3.16.5. Analyst commentary
    • 24.3.16.6. Strategy Overview
      • 24.3.16.6.1. Marketing Strategy
      • 24.3.16.6.2. Product Strategy
      • 24.3.16.6.3. Channel Strategy
  • 24.3.17. Thuasne SAS
    • 24.3.17.1. Overview
    • 24.3.17.2. Product Portfolio
    • 24.3.17.3. Key Financials
    • 24.3.17.4. Sales Footprint
    • 24.3.17.5. Analyst commentary
    • 24.3.17.6. Strategy Overview
      • 24.3.17.6.1. Marketing Strategy
      • 24.3.17.6.2. Product Strategy
      • 24.3.17.6.3. Channel Strategy
  • 24.3.18. DJO Global
    • 24.3.18.1. Overview
    • 24.3.18.2. Product Portfolio
    • 24.3.18.3. Key Financials
    • 24.3.18.4. Sales Footprint
    • 24.3.18.5. Analyst commentary
    • 24.3.18.6. Strategy Overview
      • 24.3.18.6.1. Marketing Strategy
      • 24.3.18.6.2. Product Strategy
      • 24.3.18.6.3. Channel Strategy
  • 24.3.19. ORTHOSERVICE AG
    • 24.3.19.1. Overview
    • 24.3.19.2. Product Portfolio
    • 24.3.19.3. Key Financials
    • 24.3.19.4. Sales Footprint
    • 24.3.19.5. Analyst commentary
    • 24.3.19.6. Strategy Overview
      • 24.3.19.6.1. Marketing Strategy
      • 24.3.19.6.2. Product Strategy
      • 24.3.19.6.3. Channel Strategy
  • 24.3.20. Breg, Inc.
    • 24.3.20.1. Overview
    • 24.3.20.2. Product Portfolio
    • 24.3.20.3. Key Financials
    • 24.3.20.4. Sales Footprint
    • 24.3.20.5. Analyst commentary
    • 24.3.20.6. Strategy Overview
      • 24.3.20.6.1. Marketing Strategy
      • 24.3.20.6.2. Product Strategy
      • 24.3.20.6.3. Channel Strategy
  • 24.3.21. Advanced Orthopaedics
    • 24.3.21.1. Overview
    • 24.3.21.2. Product Portfolio
    • 24.3.21.3. Key Financials
    • 24.3.21.4. Sales Footprint
    • 24.3.21.5. Analyst commentary
    • 24.3.21.6. Strategy Overview
      • 24.3.21.6.1. Marketing Strategy
      • 24.3.21.6.2. Product Strategy
      • 24.3.21.6.3. Channel Strategy
  • 24.3.22. ALGEOS
    • 24.3.22.1. Overview
    • 24.3.22.2. Product Portfolio
    • 24.3.22.3. Key Financials
    • 24.3.22.4. Sales Footprint
    • 24.3.22.5. Analyst commentary
    • 24.3.22.6. Strategy Overview
      • 24.3.22.6.1. Marketing Strategy
      • 24.3.22.6.2. Product Strategy
      • 24.3.22.6.3. Channel Strategy
  • 24.3.23. Hollister Incorporated
    • 24.3.23.1. Overview
    • 24.3.23.2. Product Portfolio
    • 24.3.23.3. Key Financials
    • 24.3.23.4. Sales Footprint
    • 24.3.23.5. Analyst commentary
    • 24.3.23.6. Strategy Overview
      • 24.3.23.6.1. Marketing Strategy
      • 24.3.23.6.2. Product Strategy
      • 24.3.23.6.3. Channel Strategy
  • 24.3.24. ConvaTec Group plc
    • 24.3.24.1. Overview
    • 24.3.24.2. Product Portfolio
    • 24.3.24.3. Key Financials
    • 24.3.24.4. Sales Footprint
    • 24.3.24.5. Analyst commentary
    • 24.3.24.6. Strategy Overview
      • 24.3.24.6.1. Marketing Strategy
      • 24.3.24.6.2. Product Strategy
      • 24.3.24.6.3. Channel Strategy
  • 24.3.25. Coloplast A/S
    • 24.3.25.1. Overview
    • 24.3.25.2. Product Portfolio
    • 24.3.25.3. Key Financials
    • 24.3.25.4. Sales Footprint
    • 24.3.25.5. Analyst commentary
    • 24.3.25.6. Strategy Overview
      • 24.3.25.6.1. Marketing Strategy
      • 24.3.25.6.2. Product Strategy
      • 24.3.25.6.3. Channel Strategy
  • 24.3.26. Medline Industries Inc.
    • 24.3.26.1. Overview
    • 24.3.26.2. Product Portfolio
    • 24.3.26.3. Key Financials
    • 24.3.26.4. Sales Footprint
    • 24.3.26.5. Analyst commentary
    • 24.3.26.6. Strategy Overview
      • 24.3.26.6.1. Marketing Strategy
      • 24.3.26.6.2. Product Strategy
      • 24.3.26.6.3. Channel Strategy
  • 24.3.27. Invacare Corporation
    • 24.3.27.1. Overview
    • 24.3.27.2. Product Portfolio
    • 24.3.27.3. Key Financials
    • 24.3.27.4. Sales Footprint
    • 24.3.27.5. Analyst commentary
    • 24.3.27.6. Strategy Overview
      • 24.3.27.6.1. Marketing Strategy
      • 24.3.27.6.2. Product Strategy
      • 24.3.27.6.3. Channel Strategy

25. Assumptions and Acronyms Used

26. Research Methodology